Clinical Trials in the Category "Hematologic Neoplasms"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL |
Sandra Jeane Horning |
Lymphoma, Hodgkin Disease
Hodgkin Disease Blood Cancer | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD |
Robert Lowsky |
Myeloproliferative Disorders
Blood Cancer Myelodysplastic Syndromes | |
|
|||
| Allogeneic Hematopoietic Cell Transplantation Using TLI/ATG for Older Patients with Hematologic Malignancies |
Robert Lowsky |
Blood Cancer | |
|
|||
| Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies |
Robert Lowsky |
Blood Cancer | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Treatment for Acute Graft-Versus-Host Disease
(No longer recruiting) |
Laura Johnston |
Graft vs Host Disease
Blood Cancer | |
|
|||
|
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
(No longer recruiting) |
Laura Johnston |
Blood Cancer | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration